Search results for "Maintena"

showing 10 items of 394 documents

Overcoming managers’ myopic decisions in a waste collection company

2019

Purpose The purpose of this paper is to show how the changing interrelationships between fleet management, human resources and outsourcer capacity areas are likely to counterbalance managerial policies, thereby generating a performance decay. The use of system dynamics modelling in a waste collection company offered an effective contribution to support decision makers to overcoming myopic decisions. Design/methodology/approach Literature review and a case study analysis (including interviews with company actors and data gathering) offered the basis to build a system dynamics model. The model built was then used to run simulations sessions to assess alternative investments decisions. Findin…

Process managementPerformance managementMaintenanceStrategy and ManagementGeneral Decision SciencesSystem dynamicWaste collectionOperations research010501 environmental sciencesManagement Science and Operations ResearchScenario analysi01 natural sciencesSettore SECS-P/07 - Economia Aziendale0502 economics and businessLearningAlternative investmentScenario analysisHuman resourcesWaste management0105 earth and related environmental sciencesData collectionbusiness.industry05 social sciencesModelingSystem dynamicsPerformance managementFleet managementbusinessSimulation050203 business & managementFleet managementJournal of Modelling in Management
researchProduct

The effect of budesonide/formoterol maintenance and reliever therapy on the risk of severe asthma exacerbations following episodes of high reliever u…

2012

Abstract Background Divergent strategies have emerged for the management of severe asthma. One strategy utilises high and fixed doses of maintenance treatment, usually inhaled corticosteroid/long-acting β2-agonist (ICS/LABA), supplemented by a short-acting β2-agonist (SABA) as needed. Alternatively, budesonide/formoterol is used as both maintenance and reliever therapy. The latter is superior to fixed-dose treatment in reducing severe exacerbations while achieving similar or better asthma control in other regards. Exacerbations may be reduced by the use of budesonide/formoterol as reliever medication during periods of unstable asthma. We examined the risk of a severe exacerbation in the per…

Pulmonary and Respiratory MedicineBudesonideExacerbationAsthma in primary careSeverity of Illness Indexlaw.inventionRandomized controlled trialDouble-Blind MethodlawAdrenal Cortex HormonesRisk FactorsFormoterol FumarateAdministration InhalationmedicineBudesonide Formoterol Fumarate Drug CombinationHumansAnti-Asthmatic AgentsBudesonideAsthmalcsh:RC705-779Maintenance dosebusiness.industryResearchlcsh:Diseases of the respiratory systemmedicine.diseaseAsthmaBronchodilator AgentsDrug CombinationsTreatment OutcomeBudesonide/formoterolEthanolaminesAnesthesiaDisease ProgressionFormoterol FumarateDrug Therapy CombinationFormoterolbusinesshormones hormone substitutes and hormone antagonistsmedicine.drugRespiratory research
researchProduct

P149 Once-daily tiotropium Respimat® add-on to at least ICS in adult patients with symptomatic asthma: pooled safety analysis: Abstract P149 Table 1

2015

Background A high proportion of patients with asthma are symptomatic despite at least ICS maintenance therapy. Five trials aimed to evaluate the safety of tiotropium Respimat® compared with placebo Respimat®, each as add-on to at least ICS in adult patients with symptomatic asthma. Methods Five Phase III and one Phase II randomised, double-blind, placebo-controlled, parallel-group trials. PrimoTinA-asthma® (48 weeks): tiotropium Respimat® 5 µg add-on to ICS + LABA (≥800 µg budesonide or equivalent); MezzoTinA-asthma® (24 weeks): tiotropium Respimat® 5 µg or 2.5 µg add-on to ICS (400–800 µg budesonide or equivalent); GraziaTinA-asthma® (12 weeks): tiotropium Respimat® 5 µg or 2.5 µg add-on t…

Pulmonary and Respiratory MedicineBudesonideRespimatAdult patientsbusiness.industrymedicine.diseasePlacebohumanitiesrespiratory tract diseasesSafety profileMaintenance therapyAnesthesiamedicineOnce dailybusinesshuman activitiesmedicine.drugAsthmaThorax
researchProduct

How pediatricians in Spain manage the first acute wheezing episode in an atopic infant. Results from the TRAP study.

2005

Abstract Background Although the treatment of asthma has been addressed in several guidelines, the management of the first acute wheezing episode in infants has not often been evaluated. We surveyed practicing pediatricians in Spain about the treatment they would provide in a simulated case. Material and methods A random sample of 3000 pediatricians and physicians who normally treated children was surveyed. The questionnaire inquired about how they would treat a first mild-to-moderate wheezing attack in a 5-month-old boy with a personal and family history of allergy. Pediatricians were asked about their professional background. Results A total of 2347 questionnaires were returned with usefu…

Pulmonary and Respiratory MedicineHypersensitivity ImmediateAllergyPediatricsmedicine.medical_specialtyImmunologyAdrenergic beta-AntagonistsAdministration OralPrimary carePediatricsMaintenance therapyAdrenal Cortex HormonesAdrenergic beta-2 Receptor AntagonistsRecurrenceSurveys and QuestionnairesAdministration InhalationmedicineImmunology and AllergyHumansRespiratory soundsAnti-Asthmatic AgentsMetered Dose InhalersFamily historyPractice Patterns Physicians'AsthmaRespiratory Soundsmedicine.diagnostic_testBronchial Spasmbusiness.industryInhalerData CollectionMasksInfantGeneral Medicinemedicine.diseaseAsthmaSpainChild PreschoolOral steroidAcute DiseasePractice Guidelines as TopicDrug Therapy CombinationGuideline AdherencebusinessCase ManagementInhalation SpacersAllergologia et immunopathologia
researchProduct

Preliminary development of a questionnaire to measure the extra-pulmonary symptoms of severe asthma

2021

Abstract Background Research into the effects of asthma treatments on the extra-pulmonary symptoms of severe asthma is limited by the absence of a suitable questionnaire. The aim was to create a questionnaire suitable for intervention studies by selecting symptoms that are statistically associated with asthma pathology and therefore may improve when pathology is reduced. Methods Patients attending a specialist asthma clinic completed the 65-item General Symptom Questionnaire (GSQ-65), a questionnaire validated for assessing symptoms of people with multiple medically unexplained symptoms. Lung function (FEV1%) and cumulative oral corticosteroids (OCS) calculated from maintenance dose plus ex…

Pulmonary and Respiratory MedicineMalemedicine.medical_specialtyFibromyalgiaSevere asthmaExtra pulmonaryDiseases of the respiratory systemFibromyalgiaInternal medicineAsthma controlForced Expiratory VolumeSurveys and QuestionnairesmedicineHealth Status IndicatorsHumansAsthma Symptoms Fibromyalgia Questionnaire Patient reported outcomesPatient reported outcomesLung functionAsthmaAgedAged 80 and overRC705-779business.industryMaintenance doseQuestionnaireextra-pulmonary symptomsAsthma clinicMiddle Agedmedicine.diseasesparse regressionAsthmarespiratory tract diseasesSymptomslinear regressionFemaleSymptom AssessmentbusinessResearch Article
researchProduct

Phase II study of pemetrexed and cisplatin plus cetuximab followed by pemetrexed and cetuximab maintenance therapy in patients with advanced nonsquam…

2013

Abstract Objectives The aim was to determine if combined pemetrexed, cisplatin, and cetuximab was efficacious and safe as first-line treatment in advanced nonsquamous non-small cell lung cancer (NSCLC). Patients and methods In this single-arm, multicenter clinical trial, patients with Stage IIIB/IV nonsquamous NSCLC received first-line therapy consisting of pemetrexed (500mg/m 2 ) and cisplatin (75mg/m 2 ) on Day 1 (21-day cycles) plus weekly cetuximab (400mg/m 2 loading dose, then 250mg/m 2 ) for 4–6 cycles. Non-progressing patients received maintenance therapy consisting of pemetrexed and cetuximab as above until disease progression. All patients received vitamin supplementation, dexameth…

Pulmonary and Respiratory MedicineOncologyAdultMaleCancer Researchmedicine.medical_specialtyGuanineLung NeoplasmsPhases of clinical researchCetuximabPemetrexedAntibodies Monoclonal HumanizedLoading doseMaintenance ChemotherapyTranslational Research BiomedicalMaintenance therapyGlutamatesInternal medicineCarcinoma Non-Small-Cell LungAntineoplastic Combined Chemotherapy ProtocolsmedicineClinical endpointHumansLung cancerSurvival rateAgedNeoplasm StagingCetuximabbusiness.industryInduction ChemotherapyMiddle Agedmedicine.diseasePemetrexedTreatment OutcomeOncologyFemaleCisplatinbusinessmedicine.drugLung cancer (Amsterdam, Netherlands)
researchProduct

Investigation and management of residual sleepiness in CPAP-treated patients with obstructive sleep apnoea: the European view

2022

International audience; Excessive daytime sleepiness (EDS) is a major symptom of obstructive sleep apnoea (OSA), defined as the inability to stay awake during the day. Its clinical descriptors remain elusive, and the pathogenesis is complex, with disorders such as insufficient sleep and depression commonly associated. Subjective EDS can be evaluated using the Epworth Sleepiness Scale, in which the patient reports the probability of dozing in certain situations; however, its reliability has been challenged. Objective tests such as the multiple sleep latency test or the maintenance of wakefulness test are not commonly used in patients with OSA, since they require nocturnal polysomnography, da…

Pulmonary and Respiratory MedicineSleep Apnea ObstructiveSleepinessReproducibility of ResultsSíndromes d'apnea del sonDisorders of Excessive SomnolenceSettore MED/10 - Malattie Dell'Apparato RespiratorioEpworth Sleepiness ScaleObstructive sleep apnea[SDV.MHEP.PSR]Life Sciences [q-bio]/Human health and pathology/Pulmonology and respiratory tractmaintenance of wakefulness testHumanswake promoting agents[SDV.SPEE]Life Sciences [q-bio]/Santé publique et épidémiologieHuman medicineWakefulnessSon--PacientsEuropean Respiratory Review
researchProduct

P123 Inhaled corticosteroid plus long-acting β2-agonist therapy is overused in the treatment of patients with chronic obstructive pulmonary disease: …

2015

Rationale Inhaled corticosteroid (ICS) plus long-acting β2-agonist (LABA) therapy is indicated for different patient groups with chronic obstructive pulmonary disease (COPD) in the USA and Europe. In the previous version of the Global initiative for chronic Obstructive Lung Disease (GOLD) recommendations, the use of ICS plus LABA therapy was restricted to patients with severe and very severe lung-function impairment and frequent exacerbations, with overtreatment in milder patient populations well documented. The current GOLD document recommends the use of ICS plus LABA maintenance therapy for patients in categories C and D. Methods We present post hoc analyses from the two pivotal 1-year TO…

Pulmonary and Respiratory Medicinemedicine.medical_specialtyCOPDCombination therapyPost hocbusiness.industrymedicine.drug_classPulmonary diseasemedicine.diseaseObstructive lung diseaseMaintenance therapyInternal medicineConcomitantmedicinePhysical therapyCorticosteroidbusinessThorax
researchProduct

EAN/ERS/ESO/ESRS statement on the impact of sleep disorders on risk and outcome of stroke.

2020

BACKGROUND Sleep disorders are highly prevalent in the general population and may be linked in a bidirectional fashion to stroke, which is one of the leading causes of morbidity and mortality. AIM Four major scientific societies established a task force of experts in neurology, stroke, respiratory medicine, sleep medicine and methodology to critically evaluate the evidence regarding potential links and the impact of therapy. MATERIALS AND METHODS Thirteen research questions were evaluated in a systematic literature search using a stepwise hierarchical approach: first, systematic reviews and meta-analyses; second, primary studies post-dating the systematic reviews/meta-analyses. A total of 4…

Pulmonary and Respiratory Medicinemedicine.medical_specialtyPeriodic limb movement disorderNeurologymedicine.medical_treatmentinsomniaPopulationsleep apnea RLS insomnia strokerestless legs030204 cardiovascular system & hematologySettore MED/10 - Malattie Dell'Apparato RespiratorioSleep medicine03 medical and health sciencessleep disordered breathing0302 clinical medicineRestless Legs SyndromeSleep Initiation and Maintenance DisordersInsomniamedicinePrevalenceinsomnia outcome PLMS restless legs risk sleep disordered breathing sleep disorders strokeHumansContinuous positive airway pressure030212 general & internal medicineRisk factoreducationIntensive care medicinePLMSStrokeriskeducation.field_of_studySleep disorderSleep Apnea ObstructiveContinuous Positive Airway Pressurebusiness.industryMiddle Agedmedicine.diseasestrokeStrokeSystematic reviewNeurologyMeta-analysisoutcomesleep disordersNeurology (clinical)medicine.symptombusiness030217 neurology & neurosurgeryThe European respiratory journal
researchProduct

Maintaining information in Short-Term Memory between 2 and 6 years old of age : temporal forgetting and helping in maintaining the goal

2014

Working memory is an essential component of thought that is highly involved in learning and academic achievement. However, it is rarely studied in preschoolers, mainly because of a lack of suitable paradigms. Therefore, this thesis investigated the functioning of working memory in children between 2 and 6 years. For this purpose, two original paradigms were used. They were designed to be close to game situations which should help young children to focus their attention on the task. Firstly it was shown that the recall performance decreased over time, even in the absence of an interfering task. Children of this age therefore use a passive maintenance, i.e. without spontaneously implementing …

Rate of forgettingPreschoolersMaintien passifWorking memoryHelping goal maintenanceAide au maintien du butMémoire de travailMise en œuvre motriceImplementation of motor activity[SHS.PSY] Humanities and Social Sciences/PsychologyIndice visuelVitesse d’oubli de l’informationPassive maintenanceVisual clueEnfants d’âge préscolaire
researchProduct